Table of Contents Author Guidelines Submit a Manuscript
Interdisciplinary Perspectives on Infectious Diseases
Volume 2016, Article ID 6937509, 5 pages
Research Article

Epidemiological Mapping of Human Onchocerciasis in Transmission Suspected Districts of Bale, Borena, and West Arsi Zones of Eastern Ethiopia

1Ethiopian Public Health Institute (EPHI), Addis Ababa, Ethiopia
2African Program for Onchocerciasis Control (APOC), Ouagadougou, Burkina Faso

Received 26 March 2016; Revised 17 July 2016; Accepted 9 August 2016

Academic Editor: Subhada Prasad Pani

Copyright © 2016 Sindew Mekasha Feleke et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Onchocerciasis is mainly found in western part of Ethiopia and there is no evidence of transmission in the east ward. However, some zones (Bale, Borena, and West Arsi) are suspected for transmission given the area has fast flowing rivers and is covered with vegetation. Therefore, this study was conducted to map onchocerciasis transmission in those zones. About 19 villages were selected based on proximity to the rivers, representation of districts, zones, and vegetation covers, whereas the study participants, all village residents of age > 5 years with good health condition, were skin sniped and examined using microscopy. In this study a total of 2560 study participants were surveyed of which 1332 were female (52%) and 122 were male (48%). The age group of 21–30 years was highest (34.4%) and that of age > 51 years was the lowest (3.1%) study participants. The survey result revealed that none of the study participants regardless of age, sex, and location demonstrated skin snip Onchocerca microfilariae. The prevalence of microfilariae and community microfilarial load (CMFL) were 0% and 0 mf/s, respectively. The finding implied that there is no onchocerciasis in the area and, therefore, there is no need for interventions. Black fly distribution, cytotaxonomic study, and intraborder cross transmission monitoring are recommended.

1. Introduction

Onchocerciasis (river blindness) is a neglected tropical parasitic disease (NTD) caused by a filarial nematode worm called Onchocerca volvulus encapsulated in nodules under the skin. Female Onchocerca volvulus worms produce thousands of microfilariae which exit the nodules, move into the dermis, and enter the eye causing cutaneous and eye disease [1, 2]. Microfilaria picked up by black flies, also called Simulium flies, during a blood meal will develop into infectious stages (L3) and are transmitted to another person during subsequent bites [3, 4]. The disease is endemic in Latin America, Yemen, and Africa [5, 6]. Onchocerciasis causes high morbidity, psychosocial problems, and reduced agricultural productivity [3]. It is estimated that approximately 37.2 million people are infected and 1 million blinded or are visually impaired in 38 endemic countries around the world [3]. Ethiopia is one of the countries with high burden of onchocerciasis in the world. More than 28 million people who live in the surveyed endemic areas of Ethiopia are affected by the disease or are at high risk of infection [5]. However, there was no complete national mapping of onchocerciasis. Large parts of eastern Ethiopia remains unmapped although it is suspected for transmission; therefore, the full distribution of the disease and the status of transmission were not ascertained [5, 7]. The national onchocerciasis programme started in 2001 with the objective of controlling the disease to the level below public health importance. However, in 2012, the national onchocerciasis programme objective changed from control to elimination by interruption of transmission until 2020. The main strategy of elimination is by means of community based ivermectin (Mectizan®) distribution donated by Merck & Co. since 1987 to all who need it for as long as necessary [6, 8]. The annual or semiannual treatment of community using the drug ivermectin rapidly kills the microfilariae and reduces the fertility of adult female worms but does not kill them [1, 911]. Hence, it is used to control morbidity and to interrupt and ultimately eliminate transmission by clearing the skin microfilariae below the level needed for transmission by the black fly although there are flies biting. The goal of onchocerciasis elimination by 2020 necessitates the delineation of transmission boundaries of endemic areas and suspected adjacent districts. The disease is found, historically and as confirmed by several studies, in the northern, northwestern, western, and southwestern part of the country which have many flowing rivers and vegetation covers that favor fly breeding and are suitable for river blindness transmission. Although the ONCHOSIM prediction modeling showed that eastern Ethiopia is not suitable for onchocerciasis transmission [7] this study was conducted to confirm the transmission status with primary parasitological data collection. The national onchocerciasis elimination guideline also stated that the transmission status of onchocerciasis in the remaining part of the country needs to be checked if there is any low level transmission that potentially recurs later. The West Arsi, Bale, and Borena zones are administrative zones, previously unmapped, high vegetation coverage favorable for fly breeding, and were selected to undertake this survey.

2. Materials and Methods

The survey was carried out in 19 villages found in 10 districts within 3 administrative zones of Oromia regional state (Bale, Borena, and West Arsi) (Figure 1) from September to October 2014. The area has mountains, flowing rivers, tributaries, and vegetation covers. The Bale mountain national park is also located in Bale zone. The villages were selected from each district based on close location along the river side as first-line community and representation of the districts. All permanent village residents above the age of 5 and with good health condition (not critically ill) were included in the study. The community sensitization and mobilization were done by the health extension workers and village leaders. The survey procedure was started first by holding meeting with the community and local authority members on the need and importance of the study, mobilizing them for full participation, and informing them about their right to decide to participate in the examination or not. Verbal informed consent was obtained at the point of registration and/or examination from all individuals, parents, or legal guardians before the commencement of the examination. After obtaining their consent, the registration of all household members of the village residents was carried out through interviews conducted with household heads of the selected villages or any of adult family members. The demographic information, clinical examinations (skin examination), and skin sample collection were carried out for each study participant. Using sterilized biopsy punch two skin snips were taken from left and right iliac crest from each household member above the age of 5. The skin sample was immediately transferred to the microtitration plate well containing normal saline solution and was kept at room temperature for 24 hours [2, 4, 12, 13]. The well numbers corresponding to the study participants were recorded on the patient information form. When all the 96 plate wells were full, the plate was sealed with a transparent adhesive tape and kept at room temperature. After 24 hours incubation, the fluid from each well was transferred to a slide and examined under a microscope for the presence of microfilaria under high power (40x) magnification [1, 10]. The results of the left and right iliac crest skin samples were recorded on the result form. All the demographic and parasitological data were entered and analyzed in Microsoft Excel and Epi Info, Version 3.1.1 CDC, USA.

Figure 1: Zonal map of Ethiopia with water lines and study areas (Bale, Borena, and W. Arsi zones).

The ethical approval for this study was obtained from Ethiopian Public Health Institute (EPHI) scientific and ethical review committee after the protocol being reviewed.

3. Results

Out of the total 2560 study participants 1332 were female (52%) and 1228 were male (48%). The age groups from 21 to 30 years were the highest age group study participants (34.4%) and those of age > 51 years were lowest participants (3.1%) (Table 1). The results showed that no skin microfilariae of onchocerciasis were observed from any of 2560 study participants (Table 2). The prevalence of microfilariae and community microfilarial load (CMFL) by district, zone, and out of the total study participants were 0% and 0 mf/s in all 19 villages (Table 2). Skin rash and itching observed in eighty one (3.2%) study participants from Nensebo and Arena Buluq districts possibly associated with personnel hygiene and scabies.

Table 1: Age category of study participants and microfilariae prevalence (Mf).
Table 2: Microfilaria (Mf) prevalence per village, districts, and zones.

4. Discussion

Several epidemiological studies of onchocerciasis were carried out by various investigators [14, 15] and established the prevalence from hypo- to hyperendemicity level in different parts of the country based on which elimination program implementation is instituted and ongoing [5, 13]. They have also reported the variation in prevalence with sex and age groups [16, 17]. The Ethiopian onchocerciasis elimination guideline [5] stated that an onchocerciasis implementation unit (districts) should be treated if the microfilarial prevalence is above 2%. In order to establish strong elimination programme, a complete map of the disease transmission boundary and community based ivermectin treatment with 100% geographical and >80% therapeutic coverage are basic steps to achieve elimination [2, 5, 14, 18]. In Ethiopia, large majority of the country’s onchocerciasis transmission status was unknown [5, 7]. The national onchocerciasis elimination guideline [5] indicated the need to assess the transmission status in those unknown areas and identify intervention eligible communities and or document the findings for the country elimination dossier preparation if no transmission is ascertained in the area. However, our study result revealed that none of the skin samples demonstrated any Onchocerca microfilariae during microscopic examination with all age groups and sex of study subjects. Therefore, our study finding is important to inform policy makers that there is no onchocerciasis in the study areas; thus, intervention should be strengthened in known endemic adjacent transmission zones to enhance elimination and prevent expansion of transmission to nonendemic transmission free areas.

5. Conclusion

Based on the parasitological data, there is no human onchocerciasis in Bale, Borena, and West Arsi zones of eastern Ethiopia. Further operational research on onchocerciasis vector (Simulium fly) distribution assessment and xenomonitoring and cytotaxonomy study to monitor intraborder cross transmission is recommended.

Competing Interests

The authors declare that there are not any competing interests.

Authors’ Contributions

All authors read and approved the final version of the manuscript.


Th authors duly acknowledge the African Programme for Onchocerciasis Control (APOC) for financial and technical support. The Ethiopian Public Health Institute, EPHI, managements support to undertake this survey as a host institute is appreciated. They also thank the community leaders and the community for accepting to be part of this study.


  1. M. Katabarwa, A. Eyamba, P. Habomugisha et al., “After a decade of annual dose mass ivermectin treatment in Cameroon and Uganda, onchocerciasis transmission continues,” Tropical Medicine and International Health, vol. 13, no. 9, pp. 1196–1203, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. A. H. Tekle, E. Elhassan, S. Isiyaku et al., Impact of Long-Term Treatment of Onchocerciasis with Ivermectin in Kaduna State, Nigeria: First Evidence of the Potential for Elimination in the Operational Area of the African Programme for Onchocerciasis Control, 2012.
  3. WHO, Conceptual and Operational Framework of Onchocerciasis Elimination with Ivermectin Treatment, African Programme for Onchocerciasis Control, 2012.
  4. M. N. Katabarwa, A. Eyamba, P. Nwane et al., “Fifteen years of annual mass treatment of onchocerciasis with ivermectin have not interrupted transmission in the west region of Cameroon,” Journal of Parasitology Research, vol. 2013, Article ID 420928, 12 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. Federal Ministry of Health (FMoH), Guidelines for Onchocerciasis Elimination in Ethiopia, Federal Ministry of Health (FMoH), Addis Ababa, Ethiopia, 2014.
  6. B. Colatrella, “The mectizan donation program: 20 years of successful collaboration—a retrospective,” Annals of Tropical Medicine and Parasitology, vol. 102, supplement 1, pp. S7–S11, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. H. G. M. Zouré, M. Noma, A. H. Tekle et al., “The geographic distribution of onchocerciasis in the 20 participating countries of the African Programme for Onchocerciasis Control: (2) pre-control endemicity levels and estimated number infected,” Parasites & Vectors, vol. 7, no. 1, article 326, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. H. R. Taylor, M. Pacqué, B. Muñoz, and B. M. Greene, “Impact of mass treatment of onchocerciasis with ivermectin on the transmission of infection,” Science, vol. 250, no. 4977, pp. 116–118, 1990. View at Publisher · View at Google Scholar · View at Scopus
  9. H. S. Key, “A simple technique to assess the total number of Onchocerca volvulus microfilariae in skin snips,” Tropenmedizin und Parasitologie, vol. 29, no. 1, pp. 51–54, 1978. View at Google Scholar · View at Scopus
  10. A. Crump and S. Omura, “Ivermectin, ‘Wonder drug’ from Japan: the human use perspective,” Proceedings of the Japan Academy Series B: Physical and Biological Sciences, vol. 87, no. 2, pp. 13–28, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. E. W. Cupp and M. S. Cupp, “Short report: impact of ivermectin community-level treatments on elimination of adult Onchocerca volvulus when individuals receive multiple treatments per year,” The American Journal of Tropical Medicine and Hygiene, vol. 73, no. 6, pp. 1159–1161, 2005. View at Google Scholar · View at Scopus
  12. WHO, “Onchocerciasis and its control. Report of a WHO Expert Committee on Onchocerciasis Control,” World Health Organization Technical Report Series, vol. 852, pp. 1–104, 1995. View at Google Scholar
  13. M. Noma, H. G. M. Zouré, A. H. Tekle, P. A. I. Enyong, B. E. B. Nwoke, and J. H. F. Remme, “The geographic distribution of onchocerciasis in the 20 participating countries of the African Programme for Onchocerciasis Control: (1) priority areas for ivermectin treatment,” Parasites & Vectors, vol. 7, article 325, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. L. E. Coffeng, S. D. S. Pion, S. O'Hanlon et al., “Onchocerciasis: the pre-control association between prevalence of palpable nodules and skin microfilariae,” PLoS Neglected Tropical Diseases, vol. 7, no. 4, Article ID e2168, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. L. A. Kelly-Hope, T. R. Unnasch, M. C. Stanton, and D. H. Molyneux, “Hypo-endemic onchocerciasis hotspots: defining areas of high risk through micro-mapping and environmental delineation,” Infectious Diseases of Poverty, vol. 4, no. 1, article 36, 2015. View at Publisher · View at Google Scholar
  16. C. I. Okonkwo, I. I. Romanus, A. T. Eze, A. E. Oji, and O. N. Collins, “Epidemiology of human onchocerciasis among farmers in Ebonyi State, Nigeria,” International Journal of Medicine and Medical Sciences, vol. 2, no. 8, pp. 246–250, 2010. View at Google Scholar
  17. H. Carabin, M. Escalona, C. Marshall et al., “Prediction of community prevalence of human onchocerciasis in the Amazonian onchocerciasis focus: bayesian approach,” Bulletin of the World Health Organization, vol. 81, no. 7, pp. 482–490, 2003. View at Google Scholar · View at Scopus
  18. Federal Ministry of Health (FMoH), National Neglected Tropical Disease Master Plan 2015–2020, Federal Ministry of Health (FMoH), Addis Ababa, Ethiopia, 2015.